Published online Sep 15, 1996. doi: 10.3748/wjg.v2.i3.134
Revised: August 9, 1996
Accepted: August 23, 1996
Published online: September 15, 1996
AIM: To prevent hepatic metastasis by regional adjuvant chemotherapy after radical surgery for colon cancer.
METHODS: A nude mouse model of human colon cancer (HCC) was used to evaluate the prevention of metastasis of HCC cells following the application of early postoperative intraperitoneal (IP) high-dose 5-fluorouracil chemotherapy.
RESULTS: The incidence of liver metastasis was decreased by 40%, and the mean number of metastatic liver nodules was reduced by 50.89%. Compared with controls, 5-FU 40 mg in NS 40 mL/kg IP for 2 consecutive days prolonged mean survival by 48.21%.
CONCLUSION: IP is a promising and effective novel regional adjuvant chemotherapy for the prevention of liver metastasis of HCC cells after radical surgery for colon cancer.